Projects
1.2023-2028: National Key R&D Program: Spatiotemporal Intervention Techniques for Tumor Cell Death by using Synthetic Biology Strategies (In progress).
2.2022-2027: National Key R&D Program: Role of Stem Cells in the Pathogenesis and Damage Repair Mechanisms of Respiratory System Exposed to COVID-19 (In progress).
3.2025-2027: Shenzhen-Hong Kong Joint Funding Program (Type A): Study on Postoperative Hepatic Injury Repair via Pluripotent Stem Cell Therapy and Mitochondrial Function Restoration (In progress).
Representative Publications
(>200 peer-reviewed papers in journals including Circulation, Cell Stem Cell, Nature Metabolism, Nature Communications, etc.). To view the full publication list of Prof. Lian, please visit:
PubMed:https://pubmed.ncbi.nlm.nih.gov/?term=Lian+Qizhou&sort=date
Google Scholar:https://scholar.google.com/citations?user=I1j8ZWcAAAAJ&hl=en
Representative Papers(* Corresponding / Co-Corresponding Author)
1.Su Q, Long Y, Duan F, Lian Q.scBOA: Bayesian optimization of single-cell analysis pipelines for robust annotation and discovery.Nature Communications (in press), 2026.
2.Chen L, Zhai X, Chen S, et al., Lian Q.ITLN1 suppresses colorectal cancer progression by orchestrating neutrophil maturation and spatial organization.Nature Communications (in press), 2026.
3.Zeng H, Zheng L, Tao R, et al., Lian Q.Repurposing a small molecule plant hormone as a tunable ON-switch for CAR-T cell immunotherapy.Advanced Science,August 21e77020, 2026.
4.Zhang Z, Jiang H, Huang L, et al., Lian Q.Lentivirus-modified hematopoietic stem cell gene therapy for advanced symptomatic juvenile metachromatic leukodystrophy: a long-term follow-up pilot study.Protein Cell, 16(1): 16–27, 2025.
5.Ma CY, Zhai Y, Li CT, Liu J, Tse HF, Lian Q. Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: promises, problems and prospects.Medicinal Research Reviews, 44(3): 919–838, 2024.
6.Lian Q*, Zhang K, Zhang Z, et al., Chen HJ*. Differential effects of macrophage subtypes on SARS-CoV-2 infection in a human pluripotent stem cell-derived model.Nature Communications, 13(1): 2028, 2022.
7.Geng L, Liao B, Jin L, et al., Lian Q*, Xu A*. β-Klotho promotes glycolysis and glucose-stimulated insulin secretion via GP130.Nature Metabolism, 4(5): 608–626, 2022.
8.Jin L, Geng L, Ying L, et al., Lian Q*, Xu A*. FGF21–Sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity.Circulation,146(20): 1537–1557, 2022.
9.Zhang Z, Yan B,et al., Lian Q. Pluripotent Stem Cells Reveal Poly-unsaturated Fatty Acids-provoked Mitochondrial Stress as a Central Node Potentiating Retinal Pigmented Epithelium Degeneration in Bietti’s Crystalline Dystrophy .Molecular Therapy 2020 Jul 25;S1525-0016(20)30375-0
10.Lian Q*, Zhang Y,et al.,Tse HF*. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice.Circulation.2010 Mar 9;121(9):1113-20